Results 251 to 260 of about 398,610 (305)
Some of the next articles are maybe not open access.

AIEgens for synergistic anticancer therapy

Journal of Materials Chemistry B, 2023
To improve the precision of cancer treatment, maximize therapeutic effects, and minimize mortality, AIEgen-based synergistic therapies combining imaging technologies, phototherapy, and other therapies will be introduced and perspected in this review.
Xinyan Lyu   +7 more
openaire   +3 more sources

Cytokines in anticancer therapy

Clinics in Dermatology, 1991
Abstract Cytokines are the protein products of cells that regulate proliferation, differentiation, and functional activation. They are synthesized by a variety of cells, for example, lymphocytes, stromal cells, monocyte-macrophages, and keratinocytes. Glycoproteins such as interleukin (IL)-1, IL-2, IL-3, IL-4, IL-5, IL-6, granulocyte macrophage colony-
I U, Khan, N H, Shear
openaire   +2 more sources

PNP Anticancer Gene Therapy

Current Topics in Medicinal Chemistry, 2005
Escherichia coli purine nucleoside phosphorylase (PNP) catalyzes the cleavage of 9-(2-deoxy-beta-D-ribofuranosyl)-6-methylpurine (MeP-dR), while human PNP does not. MeP-dR is well tolerated while the cleavage product, 6-methylpurine (MeP), is highly cytotoxic.
Yang, Zhang   +3 more
openaire   +2 more sources

MDR Inhibitors for Anticancer Therapy

Anti-Cancer Agents in Medicinal Chemistry, 2022

Peter, Werner, Andreas, Hilgeroth
openaire   +2 more sources

Natural products in anticancer therapy

Current Opinion in Pharmacology, 2001
Many pharmaceutical agents have been discovered by screening natural products from plants, animals, marine organisms and microorganisms. Vincristine, irinotecan, etoposide and paclitaxel are examples of plant-derived compounds that are being employed in cancer treatment, and dactinomycin, bleomycin and doxorubicin are anticancer agents derived from ...
A B, da Rocha   +2 more
openaire   +2 more sources

Docetaxel Nanotechnology in Anticancer Therapy

ChemMedChem, 2012
AbstractTaxanes have been recognized as a family of very efficient anticancer drugs, but the formulation in use for the two main taxanes—Taxol for paclitaxel and Taxotere for docetaxel—have shown dramatic side effects. Whereas several new formulations for paclitaxel have recently appeared, such as Abraxane and others currently in various phases of ...
Pengxiang, Zhao, Didier, Astruc
openaire   +2 more sources

Inulin/oligofructose and anticancer therapy

British Journal of Nutrition, 2002
The results of our investigations indicate that dietary treatment with inulin or oligofructose incorporated in the basal diet for experimental animals: (i) reduced the incidence of mammary tumors induced in Sprague-Dawley rats by methylnitrosourea; (ii) inhibited the growth of transplantable malignant tumors in mice; and (iii) decreased the incidence ...
H S, Taper, M B, Roberfroid
openaire   +2 more sources

Sphingolipids in Anticancer Therapy

Current Medicinal Chemistry, 2006
Sphingolipids constitute a broad class of compounds with many biological functions. The sphingolipid metabolites ceramide and sphingosine are potent apoptosis inducers and produce cell cycle arrest, whereas sphingosine-1-phosphate promotes cellular growth and differentiation.
openaire   +2 more sources

Pharmacokinetic Optimisation of Anticancer Therapy

Clinical Pharmacokinetics, 1991
It is obvious that there are great problems with pharmacokinetic individualization of anticancer therapy. The strong relationship between dose intensity (total dose/unit time) and response revealed in clinical trials with some tumours provides a strong support for studies seeking relationships between the individual plasma pharmacokinetic profile and ...
J, Liliemark, C, Peterson
openaire   +2 more sources

Spermine Metabolism and Anticancer Therapy

Current Cancer Drug Targets, 2009
The natural polyamines (PA), putrescine (PUT), spermidine (SPD) and spermine (SPM) are ubiquitous constituents of eukaryotic cells. The increase of PA in malignant and proliferating cells attracted the interest of scientists during last decades, addressing PA depletion as a new strategy to inhibit cell growth. Selective enzyme inhibitors were developed
Amendola, R.   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy